ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO

  Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.

• On-Site ePRO In Action

  Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.

• More Than Document Collection: The eTMF As The Conductor Of Study Start-Up Part 1 – Site ID And Selection

  In this post, gain insight into how the eTMF can mitigate the main drivers of delay in the site ID and Selection process.

• The Importance Of Clinical Research-Focused AI In Data Management

  Everyone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.

• Save Time And Money By Using AI To Compare CRO Proposals

  Examine tried and true methods of finding outsource partners with the up-and-coming AI technologies that aim to make that process quicker, easier, and possibly cheaper.

• Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success

  A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

• From Months To Hours: MMC Medical's EDC Revolution

  Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

• Clinical Trials In The Age Of Cost Caps

  On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

• Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode

  Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.

• Tackling Feasibility In Rare Disease Clinical Trials

  Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.